
Dr. Daniel Aaron Pollyea MD
Hematologist-Oncologist | Hematology & Oncology
12605 E 16th Ave Aurora CO, 80045About
Dr. Daniel Pollyea is a hematologist oncologist practicing in Aurora, CO. Dr. Pollyea specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
- Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
- Omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.
- Expert insights into the contemporary management of older adults with acute myeloid leukemia.
- Aldehyde dehydrogenases in acute myeloid leukemia.
- The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis.
- Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.
- Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.
- Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.
- SomVarIUS: somatic variant identification from unpaired tissue samples.
- Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.
- Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
- Isocitrate dehydrogenase mutations in myeloid malignancies.
- ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.
- Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
Clinical Trials
- Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
- TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
- Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies
- Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
- PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant
Dr. Daniel Aaron Pollyea MD's Practice location
Practice At 12605 E 16th Ave
12605 E 16th Ave -Aurora, CO 80045Get Direction
Practice At 875 Blake Wilbur Drive
875 Blake Wilbur Drive -Stanford, CA 94305Get Direction
Dr. Daniel Aaron Pollyea MD's reviews
Write ReviewPatient Experience with Dr. Pollyea
Recommended Articles
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- Lymphoma News: Mother Gives Birth to Healthy Daughter after Chemo During Pregnancy
Chemotherapy has a reputation for its not-so-great side effects. As many people know, chemotherapy is known to cause off target symptoms for most cancer patients such as nausea and vomiting, hair loss, and extreme fatigue. In addition to the symptoms that one may experience during treatment, some of...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Multiple Myeloma: What is Autotransplantation?
During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- Stanford University's Linebacker Ryan Beecher Must Now Tackle Lymphoma
There's no doubt that Ryan Beecher is strong. If you want just watch one Stanford University football game, you'll see that and then some. However, he is now going to have to use a different type of strength in his battle against lymphoma.Ryan's storyWhile many had been following Ryan Beecher before...
Nearby Providers
- Dr. Devchand Paul PHD DO4700 Hale Pkwy Denver CO 80220
- Dr. Muhammad Siddique MBBS7750 S BROADWAY LITTLETON CO 80122
- Dr. SARA ROBINSON M.D.University Of Colorado Denver CO 80262
- Dr. Allen L Cohn MD4700 E. Hale Parkway, Denver CO 80220
- Ms. Ana Belen Oton MD700 Delaware St Denver CO 80204
- Dr. Douglas M Reznick MD9397 Crown Crest Blvd Parker CO 80138
Nearest Hospitals
CHILDRENS HOSPITAL COLORADOl
13123 EAST 16TH AVENUE AURORA CO 80045LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl
725 WELCH ROAD PALO ALTO CA 94304STANFORD HEALTH CAREl
300 PASTEUR DRIVE STANFORD CA 94305MENLO PARK SURGICAL HOSPITALl
570 WILLOW ROAD MENLO PARK CA 94025